Wanhainen A, van Herzeele I, Bastos Goncalves F, Bellmunt Montoya S, Berard X, Boyle JR, et al. Editor’s choice – european society for vascular surgery (ESVS) 2024 clinical practice guidelines on the management of abdominal Aorto-iliac artery aneurysms. Eur J Vasc Endovasc Surg. 2024;67(2):192–331.
Nelson PR, Kracjer Z, Kansal N, Vikram R, Bianchi C, Hashemi H, et al. A multicenter, randomized, controlled trial of totally percutaneous access versus open femoral exposure for endovascular aortic aneurysm repair (the PEVAR trial). J Vasc Surg. 2014;59(5):1181–93.
Noori VJ, Eldrup-Jørgensen J. A systematic review of vascular closure devices for femoral artery puncture sites. J Vasc Surg. 2018;68(3):887–99.
Wood DA, Krajcer Z, Sathananthan J, Strickman N, Metzger C, Fearon W, et al. Pivotal clinical study to evaluate the safety and effectiveness of the MANTA percutaneous vascular closure device: the SAFE MANTA study. Circulat: Cardiovasc Intervent. 2019;12(7):e007258.
Chaudhuri A. Effectiveness of the MANTA vascular closure device for endovascular aneurysm repair in the obese: a prospective pilot audit. Eur J Vasc Endovasc Surg. 2022;64(5):577–8.
Peeters M, Oosterveld R, Decraemer G, Wong C, Salemans P, Nouwens R, Bouwman L, Yazar O. Clinical outcomes of MANTA closure device in percutaneous endovascular aortic aneurysm repair. J Vascular Surg. 2024;79(3):569–76.
World Health Organization, Regional Office for Europe. WHO European Regional Obesity: Report 2022. World Health Organization. Copenhagen. 2022, 3–22. Licence: CC BY-NC-SA 3.0 IGO.
Hajibandeh S, Hajibandeh S, Antoniou SA, Child E, Torella F, Antoniou GA. Percutaneous access for endovascular aortic aneurysm repair: a systematic review and meta-analysis. Vascular. 2016;24(6):638–48.
Kauvar DS, Martin ED, Givens MD. Thirty-Day outcomes after elective percutaneous or open endovascular repair of abdominal aortic aneurysms. Ann Vasc Surg. 2016;31:46–51.
van Gils L, de Jaegere PPT, Roubin G, Van Mieghem NM. The MANTA vascular closure device: a novel device for large-bore vessel closure. JACC: Cardiovasc Intervent. 2016;9(11):1195–6.
Okuna S, Iida O, Shiraki T, Fujita M, Masuda M, Okamoto S, et al. Impact of calcification on clinical outcomes after endovascular therapy for superficial femoral artery disease: assessment using the peripheral artery calcification scoring system. J Endovasc Ther. 2016;23(5):731–7.
Wiseman JT, Fernandes-Taylor S, Barnes ML, Saunders RS, Saha S, Havlena J, et al. Predictors of surgical site infection after hospital discharge in patients undergoing major vascular surgery. J Vasc Surg. 2015;62(4):1023–31.
Giles KA, Wyers MC, Pomposelli FB, Hamdan AD, Avery Ching Y, Schermerhorn ML. The impact of body mass index on perioperative outcomes of open and endovascular abdominal aortic aneurysm repair from the national surgical quality improvement program, 2005–2007. J Vasc Surg. 2010;52(6):1471–7.
Chen IM, Lee TH, Chen PL, Shih CC, Chang HH. Factors in proglide® vascular closure failure in sheath arteriotomies greater than 16 French. Eur J Vasc Endovasc Surg. 2019;58(4):615–22.
Article PubMed CAS Google Scholar
Starnes BW, Andersen CA, Ronsivalle JA, Stockmaster NR, Mullenix PS, Statler JD. Totally percutaneous aortic aneurysm repair: experience and prudence. J Vasc Surg. 2006;43(2):270–6.
Lee WA, Brown MP, Nelson PR, Huber TS. Total percutaneous access for endovascular aortic aneurysm repair (“Preclose” technique). J Vasc Surg. 2007;45(6):1095–101.
Mousa AY, Campbell JE, Broce M, Abu-Halimah S, Stone PA, Hass S, et al. Predictors of percutaneous access failure requiring open femoral surgical conversion during endovascular aortic aneurysm repair. J Vasc Surg. 2013;58(5):1213–9.
Chaudhuri A. ‘Post-close’ femoral arterial haemostasis at endovascular aneurysm repair using a dedicated large-bore vascular closure device: a prospective real-world audit. Cardiovasc Intervent Radiol. 2023;46(7):835–43.
Article PubMed CAS Google Scholar
Krajcer Z, Wood DA, Strickman N, Bernardo N, Metzger C, Aziz M, et al. Pivotal Clinical study to evaluate the safety and effectiveness of the MANTA vascular closure device during percutaneous EVAR and TEVAR procedures. J Endovasc Ther. 2020;27(3):414–20.
Boussofara A, Godin M, Canville A, Baala B, Berland J, Koning R, et al. Assessment of the MANTA closure device in real-life transfemoral transcatheter aortic valve replacement: a single-centre observational study. Catheter Cardiovasc Interv. 2024;103(4):650–9.
Masiero G, D’Angelo L, Fovino LN, Fabris T, Cardaioli F, Rodinò G, et al. Real-world experience with a large bore vascular closure device during TAVI procedure: features and predictors of access-site vascular complications. Front Cardiovasc Med. 2022. https://doi.org/10.3389/fcvm.2022.832242.
Article PubMed PubMed Central Google Scholar
Medranda GA, Case BC, Zhang C, Rappaport H, Weissman G, Bernardo N, et al. Propensity-matched comparison of large-bore access closure in transcatheter aortic valve replacement using MANTA versus Perclose: a real-world experience. Catheter Cardiovasc Interv. 2021;98(3):580–5.
Kroon HG, Tonino PAL, Savontaus M, Amoroso G, Laine M, Christiansen EH, et al. Dedicated plug based closure for large bore access –The MARVEL prospective registry. Catheter Cardiovasc Interv. 2021;97(6):1270–8.
Heitzinger G, Brunner C, Koschatko S, Dannenberg V, Mascherbauer K, Halavina K, et al. A real world 10-Year experience with vascular closure devices and large-bore access in patients undergoing transfemoral transcatheter aortic valve implantation. Front Cardiovasc Med. 2021. https://doi.org/10.3389/fcvm.2021.791693.
Mahalwar G, Shariff M, Datla S, Agrawal A, Rathore SS, Arif TB, et al. Meta-analysis of ProGlide versus MANTA vascular closure devices for large-bore access site management. Indian Heart J. 2022;74(3):251–5. https://doi.org/10.1016/j.ihj.2022.03.003.
Comments (0)